08048035968
Arthritis JAKNAT 10mg Tablets trusted to Canada - Toronto | Phoenix Exim | Global Exporter

1. General Information

JAKNAT 10 mg Tablet is an immunomodulatory medicine containing tofacitinib. It works by inhibiting Janus kinase enzymes involved in inflammatory and immune-system signaling. It is prescribed for certain inflammatory autoimmune diseases when appropriate treatment has been determined by a qualified healthcare professional.

It is a prescription-only medicine and should not be started, stopped, or dose-adjusted without medical supervision.

2. Product Information

  • Brand: JAKNAT 10 mg Tablet
  • Active ingredient: Tofacitinib 10 mg
  • Drug class: Janus kinase (JAK) inhibitor
  • Dosage form: Oral tablet
  • Manufacturer/Marketer: Natco Pharma Ltd.
  • Route: Oral
  • Strength: 10 mg

The appropriate strength and dosing schedule depend on the disease being treated and the patient's individual medical circumstances.

3. Uses of JAKNAT 10 mg

Tofacitinib is used for selected inflammatory and autoimmune conditions. Depending on the applicable regulatory approval and clinical circumstances, it may be prescribed for:

  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Ulcerative colitis
  • Ankylosing spondylitis
  • Certain pediatric inflammatory conditions under specialist supervision

Current U.S. prescribing information specifies particular eligibility requirements, including inadequate response or intolerance to certain TNF-blocking therapies for several indications.

4. Benefits of This Medicine

When appropriately prescribed, tofacitinib may help:

  • Reduce inflammation associated with autoimmune disease.
  • Relieve symptoms such as joint pain, swelling, and stiffness in inflammatory arthritis.
  • Improve physical function and disease control.
  • Reduce inflammatory symptoms associated with ulcerative colitis.
  • Provide an oral treatment option for patients who meet the appropriate treatment criteria.

The benefits vary from person to person and should be weighed against the medicine's significant safety risks.

5. Side Effects of JAKNAT 10 mg

Because tofacitinib suppresses certain immune pathways, it can increase susceptibility to infections and may cause other adverse effects. Important risks include:

  • Serious bacterial, viral, fungal, and opportunistic infections, including tuberculosis.
  • Herpes zoster (shingles).
  • Changes in blood counts or liver enzymes.
  • Increased cholesterol levels.
  • Serious cardiovascular events such as heart attack or stroke.
  • Blood clots.
  • Certain malignancies.
  • Rare gastrointestinal perforation.

Tofacitinib carries prominent warnings concerning serious infections, malignancy, major cardiovascular events, thrombosis, and mortality.

6. Common Side Effects

Commonly reported adverse reactions can include:

  • Upper respiratory tract infection
  • Nasopharyngitis/common cold symptoms
  • Headache
  • Diarrhea
  • Nausea
  • Increased cholesterol
  • Rash
  • Herpes zoster
  • Increased blood pressure
  • Changes in certain laboratory values

The frequency of individual side effects can vary according to the condition being treated and the patient's treatment regimen.

7. How to Use JAKNAT 10 mg

Take JAKNAT 10 mg exactly as prescribed by your doctor.

  • Swallow the tablet with water.
  • Take it at the prescribed time each day.
  • Do not take more tablets than prescribed.
  • Do not stop treatment suddenly without consulting your doctor.
  • If you miss a dose, follow your doctor's or pharmacist's instructions rather than taking an extra dose.
  • Do not change between different strengths or dosing schedules without medical advice.

The 10 mg strength does not mean that 10 mg twice daily is appropriate for every patient or condition. Tofacitinib dosing differs according to indication and clinical circumstances, and higher doses have important safety concerns.

8. How JAKNAT 10 mg Works

Tofacitinib blocks Janus kinase enzymes, particularly JAK1 and JAK3, which participate in signaling pathways used by several inflammatory cytokines.

By reducing these signals, tofacitinib decreases excessive immune-system activity and inflammation. This can help control symptoms and disease activity in appropriately selected patients.

9. Safety Advice for JAKNAT 10 mg

Important: This medicine requires medical supervision.

  • Tell your doctor if you have an active or recurrent infection.
  • Screening for tuberculosis is important before and during treatment.
  • Tell your healthcare professional about hepatitis or other significant infections.
  • Inform your doctor about any history of cancer, blood clots, heart disease, stroke, or significant cardiovascular risk.
  • Avoid live vaccines while taking tofacitinib unless your healthcare professional specifically advises otherwise.
  • Regular blood tests may be required to monitor blood counts, liver enzymes, and cholesterol.
  • Seek urgent medical attention for symptoms suggesting a serious infection, blood clot, heart attack, or stroke.
  • Do not combine it with biologic DMARDs or potent immunosuppressants such as azathioprine or cyclosporine unless specifically directed by a specialist; current U.S. labeling generally does not recommend these combinations.
  • Discuss pregnancy and breastfeeding with your doctor before treatment. Current U.S. labeling advises against breastfeeding during therapy.

The FDA has specifically warned about increased risks of serious heart-related events, cancer, blood clots, and death with tofacitinib and certain other JAK inhibitors.

10. Frequently Asked Questions (FAQs)

Q1. What is JAKNAT 10 mg used for?
JAKNAT 10 mg contains tofacitinib and is used under medical supervision for certain inflammatory autoimmune diseases, including selected cases of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and ankylosing spondylitis.

Q2. Is JAKNAT 10 mg a prescription medicine?
Yes. It should be used only under the direction of a qualified healthcare professional.

Q3. What is the active ingredient in JAKNAT 10 mg?
The active ingredient is tofacitinib 10 mg.

Q4. Can I take JAKNAT 10 mg for an infection?
No. It is not an infection treatment. Because it can suppress immune activity, patients with serious infections require particular caution and medical evaluation.

Q5. Does JAKNAT 10 mg weaken the immune system?
It modifies/suppresses specific immune signaling pathways. Consequently, it can increase the risk of serious infections.

Q6. Can JAKNAT 10 mg be taken with other medicines?
Some combinations can increase risks or are not recommended. Provide your doctor with a complete list of medicines, supplements, and biologic therapies before starting treatment.

Q7. Does JAKNAT 10 mg require monitoring?
Yes. Doctors may monitor blood counts, liver enzymes, cholesterol, and infection status during treatment.

Q8. Is JAKNAT 10 mg suitable for everyone?
No. Patient age, diagnosis, infection history, cardiovascular risk, cancer history, other medicines, and previous treatment response all influence whether tofacitinib is appropriate.

11. Substitutes for JAKNAT 10 mg

A direct substitute should contain the same active ingredient, tofacitinib, at an appropriate strength, but the suitable product depends on the patient's indication and local availability.

Examples of tofacitinib products include:

  • Tofacitinib 10 mg tablets from other manufacturers
  • Xeljanz 10 mg (tofacitinib), where approved and available
  • Other locally approved generic tofacitinib products

Other JAK inhibitors such as upadacitinib, baricitinib, or filgotinib are not direct substitutes because they contain different active ingredients and have different indications, dosing, interactions, and safety profiles. A doctor should select any alternative.

12. SEO Keywords

JAKNAT 10 mg Tablets, JAKNAT 10 mg exporter from India, JAKNAT 10 mg tablets exporter, JAKNAT 10 mg supplier India, JAKNAT 10 mg wholesale supplier, JAKNAT 10 mg pharmaceutical exporter, Tofacitinib 10 mg tablets, Tofacitinib 10 mg exporter India, Tofacitinib tablets supplier, Tofacitinib 10 mg wholesale, JAKNAT tablets supplier from Nagpur, pharmaceutical medicine exporter Nagpur India, genuine JAKNAT 10 mg tablets, JAKNAT 10 mg international supplier, JAKNAT 10 mg for rheumatoid arthritis, Tofacitinib for rheumatoid arthritis, Tofacitinib for psoriatic arthritis, Tofacitinib for ulcerative colitis, JAK inhibitor tablets exporter, JAK inhibitor medicine supplier India, JAKNAT 10 mg export to USA, JAKNAT 10 mg export to UK, JAKNAT 10 mg export to Australia, JAKNAT 10 mg export to Singapore, JAKNAT 10 mg export to Canada, JAKNAT 10 mg export to South Korea, JAKNAT 10 mg export to UAE, Phoenix Exim pharmaceutical exporter, Phoenix Exim medicine supplier India, Indian pharma exporter for international markets.

Aug 21st, 2026 3:56 PM

Keywords